Biotechnology Stocks
| # | 過去7日 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 5006 |  SLXN Silexion Therapeutics Corp - Ordinary Shares | 0.23 USD | -8.00% | -20.69% | -43.90% | -85.71% | 1.28 M USD | ||
| 5011 |  VRAX Virax Biolabs Group Limited - Ordinary Shares | 1.99 USD | -5.69% | -11.16% | -27.11% | +192.65% | 1.15 M USD | ||
| 5046 |  SCNI Scinai Immunotherapeutics Ltd - American Depositary Shares | 1.21 USD | +7.08% | -6.92% | -27.98% | +59.21% | 419.65 K USD | ||
| 5092 |  BDRX Biodexa Pharmaceuticals plc - American Depositary Shares | 0.52 USD | -7.14% | -16.13% | -35.00% | -62.86% | 46.97 K USD | ||
| 5095 |  CDT CDT Equity Inc. - Common Stock | 0.80 USD | -4.76% | -37.50% | +95.12% | +48.15% | 25.17 K USD | ||
| 5100 |  CMND Clearmind Medicine Inc. - Common Shares | 6.60 USD | 0.00% | +816.67% | +560.00% | +573.47% | 13.04 K USD | ||
| 5134 |  GMAB Genmab A/S - American Depositary Shares | 36.05 USD | -1.64% | +4.83% | +11.06% | +13.01% | 0 USD | ||
| 5166 |  OCS Oculis Holding AG - Ordinary shares | 8.66 USD | +1.88% | -1.81% | -23.70% | -59.72% | 0 USD | ||
| 5179 |  ANL Adlai Nortye Ltd - American Depositary Shares | 15.51 USD | +10.39% | -1.59% | +3.61% | +817.75% | 0 USD | ||
| 5250 |  NVO Novo Nordisk A/S | 38.16 USD | -0.26% | +1.38% | -14.44% | -34.90% | 0 USD | ||
| 5466 |  CELG-RT Bristol-Myers Squibb Company Celegne Contingent Value Rights | 0.1149 USD | -11.62% | -11.62% | 0.00% | +198.44% | 0 USD | ||
| 6285 |  ADAP Adaptimmune Therapeutics plc - American Depositary Shares | 0.05 USD | 0.00% | 0.00% | -61.54% | -76.19% | 0 USD | ||
| 6408 |  RVMDW Revolution Medicines, Inc. - Warrant | 9.4400 USD | -12.27% | -19.45% | -17.19% | +3142.87% | 40.32 B USD | ||
| 6637 |  NAMSW NewAmsterdam Pharma Company N.V. - Warrant | 12.6500 USD | 0.00% | 0.00% | +1.04% | -39.33% | 2.54 B USD | ||
| 6709 |  DRTSW Alpha Tau Medical Ltd. - Warrant | 3.5600 USD | -1.11% | -12.10% | -11.66% | +917.14% | 1.23 B USD | ||
| 6823 |  YDESW YD Bio Limited - Warrants | 0.5000 USD | -23.08% | -28.57% | +33.33% | -76.30% | 409.87 M USD | ||
| 6953 |  SABSW SAB Biotherapeutics, Inc. - Warrant | 0.0088 USD | -27.87% | -40.94% | -42.48% | -68.79% | 262.95 M USD | ||
| 7057 |  ENGNW enGene Therapeutics Inc. - Warrants | 0.1700 USD | 0.00% | -32.00% | -5.66% | -79.01% | 119.29 M USD | ||
| 7102 |  FBIOP Fortress Biotech, Inc. - 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock | 17.78 USD | -1.33% | +9.75% | -4.10% | +149.72% | 76.87 M USD | ||
| 7105 |  NTRBW Nutriband Inc. - Warrant | 0.5500 USD | 0.00% | -32.10% | +83.33% | -67.65% | 75.37 M USD |
ニュース Biotechnology Stocks
RBCキャピタル、Rhythm Pharmaceuticalsの「アウトパフォーム」を維持、目標株価を159ドルに引き上げ
RBCキャピタル、Exelixisの「セクター・パフォーム」を維持、目標株価を45ドルに引き下げ
ADCセラピューティクス、1株1.42ドルで1,290万株、1ワラント1.32ドルで4,810万株を取得できるワラント付きで8,660万ドルのPIPE資金調達を発表；ローンおよびロイヤルティ契約の修正も確保
NutriBand、AVERSA乱用防止経皮技術の保護強化を目的として米国特許出願を提出
BioLineRx社、GLIX1を取り上げた2件の抄録が11月12日～15日に開催される神経腫瘍学会年次総会で発表されることを発表
Atrium Therapeutics、5,170,384株および最大1,134,930株を購入可能なプレファンドワラントの私募を1ユニット約7.93ドルで実施、総額5,000万ドルを発表
「ロシア、シベリアで2件目の感染報告を否定」 - Bloomberg
Gainers Biotechnology Stocks
 GRDX GridAI Technologies Corp. - Common Stock | 4.80 | +16.50% |
 CLGN CollPlant Biotechnologies Ltd. - Ordinary Shares | 3.97 | +14.74% |
 IPSC Century Therapeutics, Inc. - Common Stock | 1.46 | +14.06% |
 ADCT ADC Therapeutics SA Common Shares | 1.59 | +11.97% |
 CDTTW CDT Equity Inc. - Warrant | 0.0117 | +11.43% |
 SRZN Surrozen, Inc. - Common Stock | 27.97 | +11.26% |
ANL Adlai Nortye Ltd - American Depositary Shares | 15.51 | +10.39% |
 QNCX Quince Therapeutics, Inc. - Common Stock | 29.36 | +9.88% |
Losers Biotechnology Stocks
SABSW SAB Biotherapeutics, Inc. - Warrant | 0.0088 | -27.87% |
YDESW YD Bio Limited - Warrants | 0.5000 | -23.08% |
 CRBU Caribou Biosciences, Inc. - Common Stock | 0.48 | -22.58% |
 TCRX TScan Therapeutics, Inc. - Common Stock | 0.23 | -17.86% |
 KALA KALA BIO, Inc. - Common Stock | 0.30 | -16.67% |
 BRTX BioRestorative Therapies, Inc. - Common Stock | 1.89 | -15.62% |
 MLEC Moolec Science SA - Ordinary Shares | 4.19 | -12.89% |
 LPCN Lipocine Inc. - Common Stock | 1.93 | -12.27% |